IL2 and neoplasm: Interestingly, a direct correlation existed between the extent of the tumor specificity obtained ex vivo and the clinical outcomes of the patients – higher tumor specificity and increased production of both IL-2 and IFNγ of the ex vivo product was associated with CRs (26).